|
Market Closed -
Nasdaq
16:00:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 1.800 USD | -1.64% |
|
0.00% | +10.43% |
| 10-15 | Mayne Pharma Group Resolves US Patent Litigation With Teva Pharmaceuticals; Shares Gain 3% | MT |
| 08-25 | TherapeuticsMD, Inc. Evaluates Strategic Alternatives | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TXMD | Delayed | |
CBOE
| TXMD | Real-time | |
|
Deutsche Boerse AG
| 29TA | Delayed | |
|
Börse Stuttgart
| 29TA | Delayed | |
|
Boerse Muenchen
| 29TA | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 2 | 2.06 | 2.61 |
| Spread/Res. | -10.00% | -12.62% | -31.03% |
| Spread/Supp. | +1.12% | +1.12% | +9.09% |
| Support | 1.78 | 1.78 | 1.65 |
- Stock Market
- Stocks
- TXMD Stock
- Charts TherapeuticsMD, Inc.
Select your edition
All financial news and data tailored to specific country editions
